About: OKYO Pharma Limited, a clinical-stage ophthalmology company, develops therapies for corneal and anterior diseases in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase 2 clinical trials for the treatment of dry eye disease and neuropathic corneal pain. The company is also developing OK-201 for the treatment of acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.45 (-5.23%)
OKYONASDAQOKYO Pharma Ltd ADR
OKYO Pharma Ltd ADR share price
OKYO price activity
Último preço
$ 1,450
Variação (24h)
-0,08 USD (-5,23%)
Volume
80.21K
Volume (média 4 sem.)
-
Abertura
$ 1,53
Variação do dia
$ 1,39 - $ 1,53
Fechamento anterior
$ 1,53
Último negócio
09 Sep, 8:00 pm GMT+0
Atrasado
09 Sep, 8:00 pm GMT+0
OKYO price performance
Atrasado
09 Sep, 8:00 pm GMT+0
quote.marketSignals